GLX-002

N/A

Report date: 2026/02/06 09:27:31

Base Information

Drug NameGLX-002
Drug Alias Name波生坦分散片的改良型新药（北京亚宝）GLX002GLX-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type B antagonistsEndothelin receptor type A antagonists
TargetsEndothelin receptor type BEndothelin receptor type A
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYabao Pharmaceutical Co Ltd Beijing
China Registration ClassN/A

Develop Information

Active CompaniesYabao Pharmaceutical Co Ltd Beijing
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A